Destination

England

Travel Brief
London confronted with measles, polio, and other infectious diseases in 2025.

Travel News – England

Mar 24 • 2:38 pm CDT

Free Meningitis B Vaccinations Extended in Kent

In response to the Meningitis B (MenB) outbreak in Kent, the UK Health Security Agency (UKHSA) is expanding its efforts to provide preventive antibiotic treatment and vaccinations. As of March 19, 2026, vaccination is now available... READ →
Mar 17 • 9:45 am CDT

Invasive Meningococcal Disease Outbreak in Canterbury area of Kent Confirmed

UK health officials today confirmed that they are investigating a concerning outbreak of invasive meningococcal disease in the Canterbury area of Kent, located in southeast England. This outbreak involves invasive meningococcal disease, a serious bacterial infection... READ →
Mar 8 • 2:44 pm CDT

Eastern London Remains Poliovirus Risk

Recent detections of poliovirus in London's wastewater have led the U.S. Centers for Disease Control and Prevention (CDC) to update its global travel health notice to include the United Kingdom. This CDC advisory , classified as... READ →

England Travel Vaccines 2025

The United Kingdom, including England, Scotland, Wales, and Northern Ireland, has confirmed infectious disease outbreaks in 2025. The U.S. Centers for Disease Control and Prevention (CDC) has included the UK in Travel Health Advisories for measles and polio in 2025. The CDC recommends that you ensure you are up to date on all routine vaccines and selected travel vaccines before visiting England.

PassportHealth clinics in the United States and England offer vaccination services in Hampstead, London, and the Marylebone area.

England Urinary Tract Infection Vaccine

In the London area, the Uromune™ MV140 inactivated, oral spray, sublingual mucosal-based bacterial vaccine that reduces the recurrence of Urinary Tract Infections (rUTI) is commercailly offered.

England Chikungunya 

Travel clinics in the England offer the chikungunya vaccine.

England Mpox 2025

According to the UK Health Security Agency's epidemiological overview issued in 2025, there have been recent mpox cases in England belonging to clade Ib and clade IIb. The US FDA approved JYNNEOS® (MVA-BN®, IMVAMUNE® smallpox-mpox vaccine is commercially available in the United Kingdom.

Last reviewed
December 11, 2025